Financing led by SR One and includes participation from new and existing investors, including Point72, Viking Global Investors, Venrock Healthcare Capital Partners, New Enterprise Associates (NEA), ...

and NEXTBio Capital. ORIC intends to use the net proceeds from the proposed financing to fund research and development of its clinical-stage product candidates and research programs and for ...

and NEXTBio Capital Pro forma cash and investments expected to fund current operating plan into the second half of 2027 and through anticipated primary endpoint readout from first ORIC-944 Phase 3 ...

Amplia Therapeutics Ltd. (AU:ATX) has released an update. Amplia Therapeutics has entered into a preclinical collaboration with Korean drug screening company Next&Bio to study the effects of its ...

NEXTBio Capital, Beiersdorf Venture Capital, FemHealth Ventures and Allostery Investments LP and existing investors, including Pivotal bioVenture Partners, EQT Life Sciences, Andera Partners ...

Kaspersky Labs will gradually wind down its U.S. operations from July 20, the Russian anti-virus software maker said on Monday, nearly a month after the Biden administration announced plans to bar ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

Examples include NextBio, SolveBio and DNAstack. Here, there is uncertainty in the gain in value that can be achieved by combining and sharing genomic data, since without proper interpretation and ...

The results were uploaded to the NextBio software. The NextBio research platform was used for bioinformatic analysis. 20 The NextBio data mining strategy was divided into two parts. In the first ...

Cypher Genomics and Illumina will jointly offer pharmaceutical companies, through Illumina's sales force, a solution including Illumina's market leading sequencing technology, the NextBio platform ...

NextBio was set up to solve a problem partly created by Illumina's ($ILMN) success in next-generation sequencing (NGS)--how to make Big Data accessible and useful to ...

Publicly traded genome-analysis company Illumina Inc. says it has signed a definitive agreement to acquire NextBio Inc., whose platform software analyzes genetic data for researchers and clinicians.